Get the latest Science News and Discoveries
Neoadjuvant Immunotherapy for early stage melanoma shows positive results - EurekAlert
Immunotherapy before surgery for patients with metastatic melanoma appears to be especially successful. Fifty-nine percent of patients responds so well to this therapy that adjuvant treatment is no longer needed, according to the results of the NADINA study that were published today.
None
Or read this on Eureka Alert